Hematology, transfusion and cell therapy最新文献

筛选
英文 中文
Transcriptional regulators of fetal hemoglobin. 胎儿血红蛋白的转录调节因子
Hematology, transfusion and cell therapy Pub Date : 2024-08-17 DOI: 10.1016/j.htct.2024.06.001
Gabriela Pereira Dos Santos, Larissa Teodoro Rabi, André Alves Bezerra, Marcelo Rodrigues da Cunha, Amilton Iatecola, Victor Augusto Ramos Fernandes
{"title":"Transcriptional regulators of fetal hemoglobin.","authors":"Gabriela Pereira Dos Santos, Larissa Teodoro Rabi, André Alves Bezerra, Marcelo Rodrigues da Cunha, Amilton Iatecola, Victor Augusto Ramos Fernandes","doi":"10.1016/j.htct.2024.06.001","DOIUrl":"https://doi.org/10.1016/j.htct.2024.06.001","url":null,"abstract":"<p><p>Sickle cell anemia is a hereditary disease caused by sickle-shaped red blood cells that can lead to vaso-occlusive crises. Treatment options are currently limited, highlighting the need to develop new clinical approaches. Studies demonstrated that elevated levels of fetal hemoglobin (Hb F) are associated with a reduction of mortality and morbidity in sickle cell anemia patients. In light of this, researchers have been trying to elucidate the transcriptional regulation of Hb F to develop new therapeutic interventions. The present study aimed to present the main transcription factors of Hb F and discuss the clinical feasibility of these molecular targets. Two search strategies were used in the PubMed, SciELO, and LILACS databases between July and August 2023 to conduct this review. Manual searches were also conducted by checking references of potentially eligible studies. Eligibility criteria consisted of clinical trials and cohort studies from the last five years that investigated transcription factors associated with Hb F. The transcription factors investigated in at least four eligible studies were included in this review. As a result, 56 eligible studies provided data on the BCL11A, LRF, NF-Y, GATA1, KLF1, HRI, ATF4, and MYB factors. The studies demonstrated that Hb F is cooperatively regulated by transcription factors with the BCL11A factor appearing to be the most specific target gene for γ-globin induction. Although these data are promising, there are still significant gaps and intervention limitations due to the adverse functions of the target genes. New studies that clarify the aspects and functionalities of Hb F regulators may enable new clinical approaches for sickle cell anemia patients.</p>","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142142130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need? 慢性淋巴细胞白血病诊断:我们还需要多少种算法和评分系统?
Hematology, transfusion and cell therapy Pub Date : 2024-08-03 DOI: 10.1016/j.htct.2024.05.007
Daniel Mazza Matos
{"title":"Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?","authors":"Daniel Mazza Matos","doi":"10.1016/j.htct.2024.05.007","DOIUrl":"https://doi.org/10.1016/j.htct.2024.05.007","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study. 患者报告的急性淋巴细胞白血病治疗结果和不良反应:一项中低收入国家横断面研究。
Hematology, transfusion and cell therapy Pub Date : 2024-07-29 DOI: 10.1016/j.htct.2024.05.006
Eduardo Cerello Chapchap, Nina Melo, Denise Martins, Maria Lucia Lee, Nelson Hamerschlak
{"title":"Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study.","authors":"Eduardo Cerello Chapchap, Nina Melo, Denise Martins, Maria Lucia Lee, Nelson Hamerschlak","doi":"10.1016/j.htct.2024.05.006","DOIUrl":"https://doi.org/10.1016/j.htct.2024.05.006","url":null,"abstract":"<p><strong>Introduction: </strong>The scenario of adult patients with acute lymphoblastic leukemia treated in Brazil has not been well described yet.</p><p><strong>Methods: </strong>Four hundred patients diagnosed with acute lymphoblastic leukemia from 1981 to 2019, registered in the Brazilian lymphoma and leukemia association (ABRALE) or their caregivers were interviewed by telephone to evaluate patient-reported perceptions of diagnosis, treatment and adverse effects.</p><p><strong>Results: </strong>Overall, 203 were male with a mean age of 15.7 years and median follow-up of 6.2 years. Main presenting symptoms were fever (39 %), bleeding/ecchymosis (38 %), intense fatigue (30 %), and musculoskeletal pain (28 %). The proportion of patients diagnosed within one week of symptoms onset differed between public (17.9 %) and private healthcare (31.1 %; p-value = 0.019). Additionally, diagnostic difficulties were higher in public care: 35 % versus 22.6 % (p-value = 0.034). Only 36 patients were able to report their treatment protocols; from a list of eight reported protocols, the most common were the Brazilian Childhood Cooperative Group for Treatment of Acute Lymphoblastic Leukemia in Children (GBTLI - 10/27.8 %) and Berlin-Frankfurt-Münster (BFM - 8/22.2 %). Seventy patients (17.5 %) required treatment modification, 37.1 % due to severe adverse effects; 21.7 % received short treatment duration (≤6 months) and 16 % proceeded to allogeneic hematopoietic stem cell transplantation with 17/64 (27 %) reporting difficulties in this step, characterized as >3 months delay. Indication for transplantation was related to minimal residual disease and cranial radiotherapy; 41.7 % reported treatment-related adverse effects (range: 1-6), in particular: mood disorders (26.3 %), neurologic deficit (13.8 %), cognitive/memory impairment (12 %), and lung disease (15 %). Risk factors for adverse effects were age, indication of transplantation and living in a large city. Treatment disparities such as diagnostic and transplantation delays remain challenges in these patients.</p><p><strong>Conclusions: </strong>Urgent interventions are needed to optimize healthcare and reduce adverse effects, especially in adolescent and young adult patients.</p>","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokine release syndrome after chimeric antigen receptor T cell therapy in patients with diffuse large B-cell lymphoma: a systematic review 弥漫大 B 细胞淋巴瘤患者接受嵌合抗原受体 T 细胞疗法后的细胞因子释放综合征:系统综述
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.05.005
Andressa Rodrigues dos Santos, Daniela Zanini, Daniel Andolfatto
{"title":"Cytokine release syndrome after chimeric antigen receptor T cell therapy in patients with diffuse large B-cell lymphoma: a systematic review","authors":"Andressa Rodrigues dos Santos, Daniela Zanini, Daniel Andolfatto","doi":"10.1016/j.htct.2024.05.005","DOIUrl":"https://doi.org/10.1016/j.htct.2024.05.005","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141849108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression 对长期治疗失败的慢性骨髓性白血病(CML)患者因明显的血液学毒性而使用小剂量酪氨酸激酶抑制剂治疗,可防止血液学进展
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.03.010
Lucia Vráblová, Hana Klamova, I. Skoumalová, Jana Navrátilová, R. Janská, Janine Grohmann, Milena Holzerová, Edgar Faber
{"title":"Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression","authors":"Lucia Vráblová, Hana Klamova, I. Skoumalová, Jana Navrátilová, R. Janská, Janine Grohmann, Milena Holzerová, Edgar Faber","doi":"10.1016/j.htct.2024.03.010","DOIUrl":"https://doi.org/10.1016/j.htct.2024.03.010","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141851439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse mucocutaneous hyperpigmentation related to hydroxyurea 与羟基脲有关的弥漫性粘膜色素沉着症
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.03.009
Vishnu Sharma, Sidharth Mahajan, Vansh Bagrodia
{"title":"Diffuse mucocutaneous hyperpigmentation related to hydroxyurea","authors":"Vishnu Sharma, Sidharth Mahajan, Vansh Bagrodia","doi":"10.1016/j.htct.2024.03.009","DOIUrl":"https://doi.org/10.1016/j.htct.2024.03.009","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141840759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line 沉默 IKZF1 和 BTG1 可降低 B 细胞前体急性白血病细胞系的糖皮质激素反应
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.05.004
Amanda de Albuquerque, Bruno A. Lopes, Renan Amphilophilo Fernandes, E. Gimba, M. Emerenciano
{"title":"IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line","authors":"Amanda de Albuquerque, Bruno A. Lopes, Renan Amphilophilo Fernandes, E. Gimba, M. Emerenciano","doi":"10.1016/j.htct.2024.05.004","DOIUrl":"https://doi.org/10.1016/j.htct.2024.05.004","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141850740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review 自体骨髓移植在原发性渗出淋巴瘤中的作用:病例报告和文献综述
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.04.119
Vitor Abreu de Goes, A. Cortez, Diogo Lago Morbeck, Felipe D’Almeida Costa, Talita Máira Bueno da Silveira
{"title":"The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review","authors":"Vitor Abreu de Goes, A. Cortez, Diogo Lago Morbeck, Felipe D’Almeida Costa, Talita Máira Bueno da Silveira","doi":"10.1016/j.htct.2024.04.119","DOIUrl":"https://doi.org/10.1016/j.htct.2024.04.119","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between response to first-line steroid treatment in adult immune thrombocytopenic purpura and the course of the disease 成人免疫性血小板减少性紫癜患者对一线类固醇治疗的反应与病程之间的关系
Hematology, transfusion and cell therapy Pub Date : 2024-07-01 DOI: 10.1016/j.htct.2024.03.008
Esra Seçkin
{"title":"Relationship between response to first-line steroid treatment in adult immune thrombocytopenic purpura and the course of the disease","authors":"Esra Seçkin","doi":"10.1016/j.htct.2024.03.008","DOIUrl":"https://doi.org/10.1016/j.htct.2024.03.008","url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil. 巴西帕拉州孕妇对胎儿和新生儿溶血病的认识和临床处理。
Hematology, transfusion and cell therapy Pub Date : 2024-05-25 DOI: 10.1016/j.htct.2024.03.007
Jhemily de Nazaré Gonçalves E Silva, Andrya Maia de Souza, Fabiane Monteiro do Rosario, Laine Celestino Pinto
{"title":"Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil.","authors":"Jhemily de Nazaré Gonçalves E Silva, Andrya Maia de Souza, Fabiane Monteiro do Rosario, Laine Celestino Pinto","doi":"10.1016/j.htct.2024.03.007","DOIUrl":"https://doi.org/10.1016/j.htct.2024.03.007","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the knowledge of pregnant women and the clinical management of hemolytic disease of the fetus and newborn, as well as to describe the gestational profile, risk factors and socio-epidemiological profile of pregnant women treated at two municipal health units in Belém (Pará, Brazil).</p><p><strong>Methods: </strong>This was a cross-sectional analytical study, which consisted in the application of questionnaires to pregnant women who underwent prenatal care at the municipal health units.</p><p><strong>Results: </strong>A total of 104 pregnant women were evaluated; most were aged between 24 and 29 years old, had high school degrees (38 %), family incomes between 1 and 2 minimum wages (45 %) and blood type O+ (43 %). Regarding the gestational profile, the participants were predominantly in the third trimester of pregnancy (49 %), started prenatal care in the first gestational trimester (81 %) and were primiparous (61 %). Failures in the management of prenatal care were observed, especially with regard to access to information about the disease, since most pregnant women did not receive information about blood incompatibility during prenatal care. This led to limited knowledge about the pathology of the disease evidenced by the fact that most of the correct answers were between Questions 0-4, which were significantly associated with the women's education and income.</p><p><strong>Conclusions: </strong>Although hemolytic disease of the fetus and newborn is serious, the pregnant women in this study demonstrated little knowledge about the disease and had inadequate care by health professionals, reinforcing the importance of improving care for women's health and prenatal care.</p>","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信